O'Donnell, P. H., Arkenau, H. T., Sridhar, S. S., Ong, M., Drakaki, A., Spira, A. I., Zhang, J., Gordon, M. S., Degboe, A. N., Gupta, A. K., Mukhopadhyay, P., Huang, W., Abdullah, S. E., Angra, N., Roskos, L. K., Guo, X., & Friedlander, T. (2020). patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108. Cancer, 126(2), 432–443. http://access.bl.uk/ark:/81055/vdc_100099160176.0x000061